Connect with us

Business

Ginkgo, Mammoth among winners of NIH’s ‘Shark Tank’ for Covid-19 tests – STAT

Ginkgo Bioworks, Mammoth Biosciences, and five other companies will receive nearly $250 million to develop new Covid-19 diagnostic tests.

Published

on

post featured image
ADVERTISEMENT

The National Institutes of Health selected Ginkgo Bioworks, Mammoth Biosciences, Quidel, and four other companies to receive nearly $250 million to develop new Covid-19 diagnostic tests through its Rapid Acceleration of Diagnostics program, the agency announced Friday.
Three of the tests are intended to be processed at pharmacies or doctors offices; four are tests meant to be run in clinical labs. The money is coming from a $1.5 billion pot allocated to the NIH in April through the same law tha…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
How this family survived 40 countries living solely off bitcoin for four years – CNBC
post featured image
Market Rally Outlook Pros And Cons; 5 Stocks That Are Buys Now – Investor’s Business Daily
post featured image
A bleak outlook for millions facing cutoff of US jobless aid – Associated Press